Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin.

Due to their unique surfactant properties, poly- and perfluorinated compounds (PFCs) have been extensively used and can be found all over the environment. Concern about their environmental fate and toxicological properties has initiated several research projects. In the present study, we investigated if PFCs can compete with thyroxine (T(4), i.e., the transport form of thyroid hormone) for binding to the human thyroid hormone transport protein transthyretin (TTR). Such competitive capacity may lead to decreased thyroid hormone levels as previously reported for animals exposed to PFCs. Twenty-four PFCs, together with 6 structurally similar natural fatty acids, were tested for binding capacity in a radioligand-binding assay. The binding potency decreased in the order: perfluorohexane sulfonate > perfluorooctane sulfonate/perfluorooctanoic acid > perfluoroheptanoic acid > sodium perfluoro-1-octanesulfinate > perfluorononanoic acid, with TTR binding potencies 12.5-50 times lower than the natural ligand T(4). Some lower molecular weight compounds with structural similarity to these PFCs were > 100 times less potent than T(4). Simple descriptors based on the two-dimensional molecular structures of the compounds were used to visualize the chemical variation and to model the structure-activity relationship for the competitive potencies of the TTR-binding compounds. The models indicated the dependence on molecular size and functional groups but demanded a more detailed description of the chemical properties and data for validation and further quantitative structure-activity relationship (QSAR) development. Competitive binding of PFCs to TTR, as observed for human TTR in the present study, may explain altered thyroid hormone levels described for PFC-exposed rats and monkeys. Median human blood levels of the most potent TTR-binding PFCs are one to two orders of magnitude lower than concentration at 50% inhibition (IC(50)) values determined in the present study. In addition, this study contributes to the understanding of the bioaccumulation of PFCs in man and possibly in other wildlife species.

[1]  Hermann Fromme,et al.  Perfluorinated compounds--exposure assessment for the general population in Western countries. , 2009, International journal of hygiene and environmental health.

[2]  C. P. Swart,et al.  Halogenated contaminants in farmed salmon, trout, tilapia, pangasius, and shrimp. , 2009, Environmental science & technology.

[3]  G. Gabrielsen,et al.  Recombinant transthyretin purification and competitive binding with organohalogen compounds in two gull species (Larus argentatus and Larus hyperboreus). , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  T. Visser,et al.  Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2',4,4'-tetrabromodiphenyl ether (BDE-47). , 2008, Molecular nutrition & food research.

[5]  John W. Froehlich,et al.  Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). , 2008, Toxicology.

[6]  C. Lau,et al.  Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  D. Power,et al.  Disruption of thyroid hormone binding to sea bream recombinant transthyretin by ioxinyl and polybrominated diphenyl ethers. , 2007, Chemosphere.

[8]  Geary W Olsen,et al.  Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. , 2007, Environmental research.

[9]  H. Arp,et al.  Predicting the Partitioning Behavior of Various Highly Fluorinated Compounds , 2006 .

[10]  A. Murk,et al.  Selected Titles , 2006 .

[11]  L. Hardell,et al.  Perfluorinated chemicals in relation to other persistent organic pollutants in human blood. , 2006, Chemosphere.

[12]  Derek C G Muir,et al.  Biological monitoring of polyfluoroalkyl substances: A review. , 2006, Environmental science & technology.

[13]  M. A. Mohd,et al.  Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. , 2004, Environmental science & technology.

[14]  C. Lau,et al.  The developmental toxicity of perfluoroalkyl acids and their derivatives. , 2004, Toxicology and applied pharmacology.

[15]  Justin C. Biffinger,et al.  The Polar Hydrophobicity of Fluorinated Compounds , 2004, Chembiochem : a European journal of chemical biology.

[16]  Fumio Okada,et al.  Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Susceptible Population during Pregnancy , 2004, Environmental health perspectives.

[17]  Wenyue Hu,et al.  Binding of perfluorinated fatty acids to serum proteins , 2003, Environmental toxicology and chemistry.

[18]  M. Stanton,et al.  Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  C. Lau,et al.  Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  Yoichi Kawashima,et al.  Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. , 2003, The Journal of toxicological sciences.

[21]  C. Elcombe,et al.  Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. , 2003, Toxicology.

[22]  S. Mabury,et al.  Bioconcentration and tissue distribution of perfluorinated acids in rainbow trout (Oncorhynchus mykiss) , 2003, Environmental toxicology and chemistry.

[23]  Wenyue Hu,et al.  Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  Nathan M. Bass,et al.  Interactions of flurochemicals with rat liver fatty acid-binding protein , 2002 .

[25]  G. Olsen,et al.  Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  V. Cody Mechanisms of Molecular Recognition: Crystal Structure Analysis of Human and Rat Transthyretin Inhibitor Complexes , 2002, Clinical chemistry and laboratory medicine.

[27]  E. Kissa,et al.  Analysis of Surfactants , 2000 .

[28]  L. Johnson,et al.  Structure of human transthyretin complexed with bromophenols: a new mode of binding. , 2000, Acta crystallographica. Section D, Biological crystallography.

[29]  I. Meerts,et al.  Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  Scott A. Peterson,et al.  Inhibiting transthyretin conformational changes that lead to amyloid fibril formation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Scott A. Peterson,et al.  Discovering transthyretin amyloid fibril inhibitors by limited screening. , 1998, Bioorganic & medicinal chemistry.

[32]  C. Brack,et al.  The cerebral expression of plasma protein genes in different species. , 1995, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[33]  S. Safe,et al.  Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p-dioxins and -dibenzofurans with human transthyretin. , 1993, Chemico-biological interactions.

[34]  J. V. Vanden Heuvel,et al.  Covalent binding of perfluorinated fatty acids to proteins in the plasma, liver and testes of rats. , 1992, Chemico-biological interactions.

[35]  J. Edward Jackson,et al.  A User's Guide to Principal Components. , 1991 .

[36]  P. Larsen,et al.  Cerebrospinal fluid transthyretin in the neonate and blood–cerebrospinal fluid barrier permeability , 1989, Annals of neurology.

[37]  N. Eberhardt,et al.  Photoaffinity labeling of human thyroxine-binding prealbumin with thyroxine and N-(ethyl-2-diazomalonyl)thyroxine. , 1982, Biochemistry.

[38]  S. Wold Cross-Validatory Estimation of the Number of Components in Factor and Principal Components Models , 1978 .

[39]  S J Oatley,et al.  Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. , 1977, Journal of molecular biology.

[40]  R. Canfield,et al.  Polymorphism of Rhesus monkey serum prealbumin. Purification and partial structure. , 1973, Journal of Biological Chemistry.

[41]  Maria Dam,et al.  Perfluorinated alkylated substances (PFAS) in the Nordic environment Perfluorinated alkylated substances (PFAS) in the Nordic environment , 2004 .

[42]  K. J. Berg Interaction of chlorinated phenols with thyroxine binding sites of human transthyretin, albumin and thyroid binding globulin. , 1990 .